Ameritas Investment Partners, Inc. Aclaris Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.56 - $10.95 $11,355 - $18,954	1,731 Added 33.49%	6,900 $47,000
Q4 2022 Feb 13, 2023	BUY	$14.33 - $18.37 $9,027 - $11,573	630 Added 13.88%	5,169 $81,000
Q2 2022 Aug 12, 2022	BUY	$10.16 - $17.08 $5,689 - $9,564	560 Added 14.07%	4,539 $63,000
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $7,693 - $10,810	575 Added 16.89%	3,979 $72,000
Q2 2021 Aug 06, 2021	BUY	$17.08 - $29.6 $58,140 - $100,758	3,404 New	3,404 $60,000
Q2 2020 Aug 05, 2020	SELL	$1.04 - $1.73 $2,327 - $3,871	-2,238 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$16.46 - $20.33 $7,719 - $9,534	469 Added 26.51%	2,238 $45,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,769	1,769 $48,000

52.4M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $139M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.